• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Balkin Michael bought $170,600 worth of shares (20,000 units at $8.53) (SEC Form 4)

    12/17/24 1:23:10 PM ET
    $HRZN
    Finance: Consumer Services
    Finance
    Get the next $HRZN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Balkin Michael

    (Last) (First) (Middle)
    312 FARMINGTON AVENUE

    (Street)
    FARMINGTON CT 06032

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Horizon Technology Finance Corp [ HRZN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    12/16/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 12/16/2024 P 20,000 A $8.53(1) 20,000 I By Self as Trustee for Michael P. Balkin Revocable Trust dated 11/1/93 as Amended
    Common Stock 10,000 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported in Column 4 is the average price per share as of the transaction date. These shares were purchased in multiple transactions. Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or any security holder of the issuer.
    /s/ Michael P. Balkin 12/17/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HRZN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HRZN

    DatePrice TargetRatingAnalyst
    5/13/2025$7.00Neutral
    B. Riley Securities
    4/30/2025$6.50Neutral → Sell
    Compass Point
    12/17/2024$8.25Sell → Neutral
    Compass Point
    2/28/2024Buy → Neutral
    Ladenburg Thalmann
    1/8/2024$11.00Neutral → Sell
    B. Riley Securities
    10/17/2023$10.00Neutral → Sell
    Compass Point
    9/27/2023$11.00 → $10.50Sell → Neutral
    Compass Point
    8/4/2023$11.00Neutral → Sell
    Compass Point
    More analyst ratings

    $HRZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities resumed coverage on Horizon Technology Finance with a new price target

      B. Riley Securities resumed coverage of Horizon Technology Finance with a rating of Neutral and set a new price target of $7.00

      5/13/25 10:04:46 AM ET
      $HRZN
      Finance: Consumer Services
      Finance
    • Horizon Technology Finance downgraded by Compass Point with a new price target

      Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $6.50

      4/30/25 8:07:52 AM ET
      $HRZN
      Finance: Consumer Services
      Finance
    • Horizon Technology Finance upgraded by Compass Point with a new price target

      Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25

      12/17/24 8:05:36 AM ET
      $HRZN
      Finance: Consumer Services
      Finance